Menu
View Cart  

Recommended Products

Visit Store
Gmp-inspection-preparation-checklist-130x160

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological-risk-eval-and-mngmnt-for-md-130x160

Biological Risk Evaluation and Management for Medical Devices

Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.

Events

View All
Aug 15

Getting Real About Real World Evidence: Practical Next Steps for Drug and Device Manufacturers

Aug 16

Commissioner Gottlieb’s FDA: His First Year and a Look Ahead

Aug 22

Corporate Compliance & Liability: What Medical Product Professionals Need to Know

Aug 23

What CDER Can and Can’t Do: An Inside Look from an Agency Official

Aug 23

Clinical Trials in the Precision Medicine Era: New Techniques, New Complexity

Sep 10

Mastering EU Medical Device Regulation

Editor's Picks

View all
Grey_approved_stamp

Procleix’s Zika Assay Earns FDA Approval for Use With Panther System

The assay is also approved to test plasma or serum samples to screen other living or dead organ donors and human cells, tissues and cellular and tissue-based products.
Fda_logo_blue_2016

FDA Plans Study of Risk Information in Direct-to-Consumer Print Ads

The in-person study will consist of an hour-long 40-person pilot study, in addition to two hour-long studies with 200 voluntary participants each.

DE NOVO PHARMACEUTICALS ANNOUNCES NEW THERAPEUTIC FOCUS IN THE AREA OF METABOLIC DISEASES

KEYWORDS Daily International Pharma Alert
A A

De Novo Pharmaceuticals Ltd., a world leader in computational drug design, has announced that it is expanding its drug design business to establish a new therapeutic focus in the area of metabolic diseases. To help support this and strengthen the Company's scientific base, it has appointed a new Scientific Advisory Board.

Yahoo News (http://biz.yahoo.com/prnews/060509/ukm006.html?.v=57)

Related Products

FDA’s Device De Novo Reclassification - Webinar CD/Transcript

Device De Novo Reclassification - Webinar CD/Transcript

Risk Management in Clinical Trials: The New ICH E6 Focus

Related Events

Clinical Trials in the Precision Medicine Era: New Techniques, New Complexity

Emerging Biopharmaceutical Therapies: New Regulations, New Guidelines, New Incentives…

SOPs and Policies for the 21st Century: Why Less is More